Sterile Injectable Contract Manufacturing Market Size, Share, Trends, Industry Analysis Report: By Molecule Type, Therapeutic Application, Route of Administration, End Use, and Region

Description

List of Tables

The global sterile injectable contract manufacturing market size is expected to reach USD 50.38 billion by 2034, according to a new study by Polaris Market Research. The report "Sterile Injectable Contract Manufacturing Market Size, Share, Trends, Industry Analysis Report: By Molecule Type (Small Molecules and Large Molecules), Therapeutic Application, Route of Administration, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The sterile injectable contract manufacturing market has seen significant growth in recent years, driven by the rising demand for biologics and complex pharmaceutical formulations. The need for advanced drug delivery systems and high-quality injectable products has become paramount as the healthcare industry evolves. Sterile injectables, which include a wide range of pharmaceuticals administered via injection, are essential in various therapeutic areas, including oncology, diabetes, and vaccines. Sterile injectables have gained traction due to their ability to provide rapid therapeutic effects and the increasing preference for minimally invasive treatment options. The market is characterized by a diverse landscape of contract manufacturers that offer specialized services, including formulation development, fill-finish operations, and packaging solutions.

One of the key factors contributing to the growth of this market is the rising prevalence of chronic diseases and the increasing aging population, which demands innovative treatment solutions. Conditions such as cancer, autoimmune disorders, and infectious diseases often require injectable therapies, thus amplifying the need for sterile injectables. Additionally, the surge in demand for personalized medicine and biologics has prompted pharmaceutical companies to seek contract manufacturing organizations (CMOs) that specialize in the production of these complex formulations.

Sterile Injectable Contract Manufacturing Market Report Highlights

By molecule type, the sterile injectable contract manufacturing market for the small molecules segment is expected to experience substantial growth during the forecast period due to the ongoing research and development activities focused on new therapies.

The large molecules segment dominated the market in 2024 due to the increasing prevalence of biologics and biosimilars

Based on therapeutic application, the cancer segment accounted for a major share of the market in 2024 due to the rising incidence of cancer worldwide and the increasing demand for innovative treatments.

In the global market, North America held the largest revenue share due to robust pharmaceutical infrastructure, high healthcare spending, and a strong focus on innovation and R&D.

The market in Asia Pacific is estimated to register a significant CAGR during the forecast period owing to the increasing investments in healthcare infrastructure and a rising population.

A few global key market players are Baxter; Catalent, Inc.; Vetter Pharma-Fertigung GmbH & Co. KG; NextPharma Technologies; Cipla; FAMAR Health Care Services; Unither Pharmaceuticals; Recipharm AB; Fresenius Kabi AG; Simtra BioPharma Solutions; and Aenova Group.

Polaris Market Research has segmented the sterile injectable contract manufacturing market report on the basis of molecule type, therapeutic application, route of administration, end-use, and region:

By Molecule Type Outlook (Revenue, USD Billion, 2020-2034)

Small Molecules
Large Molecules

By Therapeutic Application Outlook (Revenue, USD Billion, 2020-2034)

Cancer
Diabetes
Cardiovascular Diseases
Central Nervous Systems Diseases
Infectious Disorders
Musculoskeletal
Anti-Viral
Others

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)
Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical Companies
Biopharmaceutical Companies
Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5151

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Molecule Types
- 3.2.1. Primary Molecule Types
- 3.2.2. Secondary Molecule Types

4. Global Sterile Injectable Contract Manufacturing Market Insights

4.1. Sterile Injectable Contract Manufacturing Market - Market Snapshot
4.2. Sterile Injectable Contract Manufacturing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising prevalence of chronic illnesses is driving the sterile injectable contract manufacturing market.
  - 4.2.1.2. Increasing advancement in technology is propelling the sterile injectable contract manufacturing market.
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. The stringent regulatory requirements are hampering the global market.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Sterile Injectable Contract Manufacturing Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Sterile Injectable Contract Manufacturing Market, by Molecule Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
5.3. Small Molecules
- 5.3.1. Global Sterile Injectable Contract Manufacturing Market, by Small Molecules, by Region, 2020-2034 (USD Billion)
5.4. Large Molecules
- 5.4.1. Global Sterile Injectable Contract Manufacturing Market, by Large Molecules, by Region, 2020-2034 (USD Billion)

6. Global Sterile Injectable Contract Manufacturing Market, by Therapeutic Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
6.3. Cancer
- 6.3.1. Global Sterile Injectable Contract Manufacturing Market, by Cancer, by Region, 2020-2034 (USD Billion)
6.4. Diabetes
- 6.4.1. Global Sterile Injectable Contract Manufacturing Market, by Diabetes, by Region, 2020-2034 (USD Billion)
6.5. Cardiovascular Diseases
- 6.5.1. Global Sterile Injectable Contract Manufacturing Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
6.6. Central Nervous System
- 6.6.1. Global Sterile Injectable Contract Manufacturing Market, by Central Nervous System, by Region, 2020-2034 (USD Billion)
6.7. Infectious Diseases
- 6.7.1. Global Sterile Injectable Contract Manufacturing Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
6.8. Musculoskeletal
- 6.8.1. Global Sterile Injectable Contract Manufacturing Market, by Musculoskeletal, by Region, 2020-2034 (USD Billion)
6.9. Anti-Viral
- 6.9.1. Global Sterile Injectable Contract Manufacturing Market, by Anti-Viral, by Region, 2020-2034 (USD Billion)
6.10. Others
- 6.10.1. Global Sterile Injectable Contract Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Sterile Injectable Contract Manufacturing Market, by Route of Administration

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
7.3. Subcutaneous (SC)
- 7.3.1. Global Sterile Injectable Contract Manufacturing Market, by Subcutaneous (SC), by Region, 2020-2034 (USD Billion)
7.4. Intravenous (IV)
- 7.4.1. Global Sterile Injectable Contract Manufacturing Market, by Intravenous (IV), by Region, 2020-2034 (USD Billion)
7.5. Intramuscular (IM)
- 7.5.1. Global Sterile Injectable Contract Manufacturing Market, by Intramuscular (IM), by Region, 2020-2034 (USD Billion)
7.6. Other
- 7.6.1. Global Sterile Injectable Contract Manufacturing Market, by Other, by Region, 2020-2034 (USD Billion)

8. Global Sterile Injectable Contract Manufacturing Market, by End-use

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
8.3. Pharmaceutical Companies
- 8.3.1. Global Sterile Injectable Contract Manufacturing Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
8.4. Biopharmaceutical Companies
- 8.4.1. Global Sterile Injectable Contract Manufacturing Market, by Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
8.5. Others
- 8.5.1. Global Sterile Injectable Contract Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Sterile Injectable Contract Manufacturing Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Sterile Injectable Contract Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Sterile Injectable Contract Manufacturing Market - North America
- 9.3.1. North America: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
- 9.3.3. North America: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.3.4. North America: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.3.5. Sterile Injectable Contract Manufacturing Market - US
  - 9.3.5.1. US: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.3.6. Sterile Injectable Contract Manufacturing Market - Canada
  - 9.3.6.1. Canada: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
9.4. Sterile Injectable Contract Manufacturing Market - Europe
- 9.4.1. Europe: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
- 9.4.3. Europe: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.4. Europe: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.4.5. Sterile Injectable Contract Manufacturing Market - UK
  - 9.4.5.1. UK: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.4.6. Sterile Injectable Contract Manufacturing Market - France
  - 9.4.6.1. France: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.4.7. Sterile Injectable Contract Manufacturing Market - Germany
  - 9.4.7.1. Germany: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.4.8. Sterile Injectable Contract Manufacturing Market - Italy
  - 9.4.8.1. Italy: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.4.9. Sterile Injectable Contract Manufacturing Market - Spain
  - 9.4.9.1. Spain: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.4.10. Sterile Injectable Contract Manufacturing Market - Netherlands
  - 9.4.10.1. Netherlands: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.4.11. Sterile Injectable Contract Manufacturing Market - Russia
  - 9.4.11.1. Russia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.4.12. Sterile Injectable Contract Manufacturing Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
9.5. Sterile Injectable Contract Manufacturing Market - Asia Pacific
- 9.5.1. Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.5.5. Sterile Injectable Contract Manufacturing Market - China
  - 9.5.5.1. China: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.5.6. Sterile Injectable Contract Manufacturing Market - India
  - 9.5.6.1. India: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.5.7. Sterile Injectable Contract Manufacturing Market - Malaysia
  - 9.5.7.1. Malaysia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.5.8. Sterile Injectable Contract Manufacturing Market - Japan
  - 9.5.8.1. Japan: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.5.9. Sterile Injectable Contract Manufacturing Market - Indonesia
  - 9.5.9.1. Indonesia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.5.10. Sterile Injectable Contract Manufacturing Market - South Korea
  - 9.5.10.1. South Korea: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.5.11. Sterile Injectable Contract Manufacturing Market - Australia
  - 9.5.11.1. Australia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.5.12. Sterile Injectable Contract Manufacturing Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
9.6. Sterile Injectable Contract Manufacturing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.6.5. Sterile Injectable Contract Manufacturing Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.6.6. Sterile Injectable Contract Manufacturing Market - UAE
  - 9.6.6.1. UAE: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.6.7. Sterile Injectable Contract Manufacturing Market - Israel
  - 9.6.7.1. Israel: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.6.8. Sterile Injectable Contract Manufacturing Market - South Africa
  - 9.6.8.1. South Africa: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.6.9. Sterile Injectable Contract Manufacturing Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
9.7. Sterile Injectable Contract Manufacturing Market - Latin America
- 9.7.1. Latin America: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.7.5. Sterile Injectable Contract Manufacturing Market - Mexico
  - 9.7.5.1. Mexico: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.7.6. Sterile Injectable Contract Manufacturing Market - Brazil
  - 9.7.6.1. Brazil: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.7.7. Sterile Injectable Contract Manufacturing Market - Argentina
  - 9.7.7.1. Argentina: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
- 9.7.8. Sterile Injectable Contract Manufacturing Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Baxter
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Catalent, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Vetter Pharma-Fertigung GmbH & Co. KG
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. NextPharma Technologies
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Cipla
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. FAMAR Health Care Services
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Unither Pharmaceuticals
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Recipharm AB
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Fresenius Kabi AG
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Simtra BioPharma Solutions
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Aenova Group
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development